Live Breaking News & Updates on Taro pharmaceutical industries ltd

Stay updated with breaking news from Taro pharmaceutical industries ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, L

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Taro Pharmaceutical Industries Ltd. (NYSE: TARO) to Sun Pharmaceutical Industries Limited. Under the terms of the proposed transactio...

Louisiana , United-states , Lewiss-kahn , Charlesc-foti-jr , Sun-pharmaceutical-industries , Taro-pharmaceutical-industries-ltd , Kahn-swick-foti , Former-attorney-general , Louisiana-charles , Kahn-swick , Taro-pharmaceutical-industries

StockNews.com Begins Coverage on Taro Pharmaceutical Industries (NYSE:TARO)

StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Free Report) in a report published on Tuesday. The brokerage issued a strong-buy rating on the stock. Separately, HC Wainwright cut Taro Pharmaceutical Industries from a buy rating to a neutral rating and set a $43.00 price target for the company. in a report […]

United-states , Israel , Canada , Investment-advisers , Taro-pharmaceutical-industries , Taro-pharmaceutical-industries-company-profile , Allspring-global-investments-holdings , Vanguard-group-inc , Taro-pharmaceutical-industries-ltd , Taro-pharmaceutical-industries-trading-down , Sg-americas-securities

StockNews.com Begins Coverage on Taro Pharmaceutical Industries (NYSE:TARO)

Research analysts at StockNews.com initiated coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Get Free Report) in a research report issued on Tuesday. The brokerage set a “strong-buy” rating on the stock. Separately, HC Wainwright downgraded Taro Pharmaceutical Industries from a “buy” rating to a “neutral” rating and set a $43.00 price target on […]

Canada , United-states , Israel , Taro-pharmaceutical-industries-company-profile , Taro-pharmaceutical-industries-trading-down , Ameritas-investment-partners-inc , News-ratings-for-taro-pharmaceutical-industries-daily , Taro-pharmaceutical-industries-ltd , Royal-bank , Tower-research-capital , Taro-pharmaceutical-industries

Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm

NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.  Kuehn Law may seek...

Justin-kuehn , Restaurant-brands-international , Carrols-restaurant-group , Innovations-inc , Taro-pharmaceutical-industries , Nasdaq , Ansys , Ansys-inc , Taro-pharmaceutical-industries-ltd , Carrols-restaurant-group-inc , Synopsys , Sun-pharmaceutical-industries

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates PGTI,

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

Daniel-sadeh , Zachary-halper , Halper-sadeh , Taro-pharmaceutical-industries-ltd , Ansys , Innovations-inc , Synopsys , Sun-pharmaceutical-industries , Ansys-inc , Nasdaq , Synopsys-inc , Pharmaceutical-industries

Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023

Taro Pharmaceutical Industries Ltd. reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was USD 157.15 million...

Taro-pharmaceutical-industries-ltd , Taro-pharmaceutical-industries , Markets ,